Intravitreal injection therapy

  • 16 Aug 2018
  • Professional Standards Committee

The aim of this guidance is to provide advice about performing all intravitreal injection therapy (IVT) as safely as possible, whilst supporting the requirement for innovative and efficient models of care to deal with the continuing increase in demand.

It is essential that:

  • Any substance injected into the eye is sterile and remains sterile when it enters the vitreous cavity
  • That the environment and equipment are safe and suitable
  • That staff are trained and up to date in delivering the procedure and know how to manage complications and adverse events

This guidance is designed for easy reference. As much of the document, as is possible, is based on published evidence. In the absence of published high-quality evidence, expert consensus has been used to make recommendations.